The cytotoxic activity of a series of 23 new isoerianin derivatives with modifications on both the A and B rings was studied. Several compounds exhibited excellent antiproliferative activity at nanomolar concentrations against a panel of human cancer cell lines. The most cytotoxic compound, isoerianin (3), strongly inhibits tubulin polymerization in the micromolar range. Moreover, isoerianin leads to G2/M phase cell-cycle arrest in H1299 and K562 cancer cells, and strongly induces apoptosis. Isoerianin also disrupts the vessel-like structures formed by human umbilical vein endothelial cells (HUVECs) in vitro, suggesting that this compound may act as a vascular disrupting agent. It clearly appears that in this compound series, the 1,1-ethane bridge encountered in isoerianin derivatives can replace the 1,2-ethane bridge of natural erianin with no loss of activity. This reinforces the bioisosteric replacement approach in the combretastatin series previously reported by our research group.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cmdc.201000456 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization.
J Control Release
December 2024
School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China. Electronic address:
Article Synopsis
- Corneal neovascularization (CNV) significantly contributes to visual impairment, and this study explores the combined effects of dasatinib and erianin, two compounds known for their anti-inflammatory and anti-angiogenic properties, on CNV cell processes.
- The researchers developed a nanostructured lipid carrier (dasa-eri-NLC) to enhance the solubility and effectiveness of dasatinib and erianin, while also mixing it with gellan gum to create a gel that improves ocular retention and drug release.
- In vivo tests showed that the dasa-eri-NLC-gel effectively reduced CNV development in a mouse model and inhibited harmful cytokines in the cornea, indicating its potential as a
Erianin alleviates cerebral ischemia-reperfusion injury by inhibiting microglial cell polarization and inflammation via the PI3K/AKT and NF-κB pathways.
Int Immunopharmacol
November 2024
Department of Neurosurgery, Dongying People's Hospital, No. 317 Dongcheng South Road, Dongying 257091, China. Electronic address:
Cerebral ischemia-reperfusion injury (CI/RI) is a leading cause of disability and mortality worldwide, with limited therapeutic options available. Erianin, a natural compound derived from traditional Chinese medicine, has been reported to possess anti-inflammatory and neuroprotective properties. This study aimed to investigate the therapeutic potential of Erianin in CI/RI and elucidate its underlying mechanisms.
View Article and Find Full Text PDFThe cytotoxic natural compound erianin binds to colchicine site of β-tubulin and overcomes taxane resistance.
Bioorg Chem
September 2024
Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address:
Erianin, a natural compound derived from Dendrobium, has shown significant anticancer properties against a wide range of cancer cells. Despite the identification of multiple mechanisms of action for erianin, none of these mechanisms fully account for its broad-spectrum effect. In this study, we aimed to identify the cellular target and underlying mechanism responsible for the broad-spectrum antitumor effects of erianin.
View Article and Find Full Text PDFErianin alleviates LPS-induced acute lung injury via antagonizing P-selectin-mediated neutrophil adhesion function.
J Ethnopharmacol
September 2024
Department of Thoracic Surgery, The Affiliated Cangnan Hospital of Wenzhou Medical University, Wenzhou, 325800, PR China. Electronic address:
Ethnopharmacological Relevance: Dendrobium officinale Kimura et Migo, known as "Tiepi Shihu" in traditional Chinese medicine, boasts an extensive history of medicinal use documented in the Chinese Pharmacopoeia. "Shen Nong Ben Cao Jing" records D. officinale as a superior herbal medicine for fortifying "Yin" and invigorating the five viscera.
View Article and Find Full Text PDFErianin serves as an NFATc1 inhibitor to prevent breast cancer-induced osteoclastogenesis and bone destruction.
J Adv Res
March 2024
Laboratory of Anti-inflammatory and Immunomodulatory Pharmacology, Innovation Program of Drug Research on Inflammatory and Immune Diseases, NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China. Electronic address:
Introduction: Breast cancer-related bone metastasis can lead to skeletal-related events (SREs), which decrease patient quality of life. Inhibition of osteoclastogenesis is a key treatment for SREs; however, the availability of clinical drugs remains limited, and all existing ones disrupt physiological bone formation, while exhibiting no effect on patient survival time.
Objectives: This study aimed to identify a novel osteoclast inhibitor for the treatment of breast cancer-induced SREs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!